Nominations

NOMINATE The Giants of Cancer Care ® program, presented by OncLive ®, recognizes and celebrates the individuals who have achieved landmark successes within the global field of oncology. Giants of Cancer Care® is the premier oncology award program honoring leaders, selected by their peers, for their remarkable achievements in oncology research and clinical practice. 2024 Nominations are now open! They will close on January 31, 2024. The Giants of Cancer Care® Steering Committee will vet all nominations to

Read the full article here

Source: www.giantsofcancercare.com

Categories: Onc News and Journals, General Medicine News

Tweets with this article

OncLive.com

Recognize greatness and nominate today for the 2024 Giants of Cancer Care® recognition program. Honor your peers for their remarkable achievements in oncology research. https://t.co/kK3abwiraG See rules here: https://t.co/uePoz9hJgw https://t.co/NABKDG5i2N

Related Articles

LLS | 4 Young Blood Cancer Survivors Look Ahead

Four young adult blood cancer survivors share what they’ve been up to and achieved since receiving the LLS Scholarship for Blood Cancer Survivors.

The Leukemia & Lymphoma Society November 27, 2024

Understanding Myelodysplastic Syndromes (MDS): Diagnosis, Classification, and Risk Assessment

Panelists discuss how myelodysplastic syndromes are diagnosed, classified, and managed, covering prevalence, symptoms, risk stratification tools, prognosis for lower-risk cases, and current treatment challenges.

OncLive.com November 27, 2024

ALLO-316 Demonstrates Early Activity and Safety in Advanced CD70-Positive ccRCC

ALLO-316, a CD70-directed CAR T-cell therapy, demonstrated preliminary efficacy and safety in CD70-positive ccRCC.

OncLive.com November 27, 2024

OCE ENGAGE: A Project Community Newsletter

A quarterly newsletter for patients living with cancer, survivors, advocates and consumers

FDA Oncology November 27, 2024

Explore the Latest Treatment Updates in EGFR-Mutated NSCLC: With Chandler Park, MD; and Stephen V. Liu, MD

Hear Chandler Park, MD and Stephen Liu, MD, explore advancements in EGFR-mutated NSCLC treatment, including TKI strategies, emerging therapies prioritizing a patient-centric approach.

OncLive.com November 27, 2024

Pancreatic Cancer Awareness Month Brings Attention to Growing Incidence and Treatment Advances

Suneel Kamath, MD, took to the OncLive X (Twitter) account during Pancreatic Cancer Awareness Month to share the importance of recognizing this disease.

OncLive.com November 27, 2024

Targeted Therapies Represent Core 2024 NCCN GI Cancer Guideline Advancements

Alan P. Venook, MD, describes challenges implementing NCCN guidelines into practice in rectal, colon, and biliary tract cancers, and advancements from 2024.

OncLive.com November 27, 2024

Myelodysplastic Syndromes | Blood Cancers Today

Myelodysplastic syndromes (MDS) are diseases of the blood cells and bone marrow. Read the latest news.

Blood Cancers Today November 27, 2024

EC Approves Frontline Tislelizumab Plus Chemo for Advanced ESCC and Gastric/GEJ Cancer

Tislelizumab plus chemotherapy has been approved in Europe for first-line advanced ESCC and gastric/GEJ adenocarcinoma.

OncLive.com November 27, 2024

Adjuvant Ribociclib Wins EU Approval for HR+/HER2– Early Breast Cancer

Adjuvant ribociclib plus endocrine therapy was approved in Europe for HR-positive/HER2-negative early breast cancer at high risk of recurrence.

OncLive.com November 27, 2024